Group 1 - The legal opinion letter confirms that the 2024 annual general meeting of Aibono Medical Technology Co., Ltd. was convened and conducted in accordance with relevant Chinese laws and regulations, as well as the company's articles of association [3][4][6] - The meeting utilized a combination of on-site and online voting, with the on-site meeting held at the company's headquarters and online voting available on June 19, 2025, from 9:15 AM to 3:00 PM [3][4] - A total of 238 shareholders participated in the voting, representing 79,668,669 shares, which accounts for 41.2801% of the total voting shares [4][6] Group 2 - The meeting's agenda included 12 proposals, with specific focus on the annual reports, financial budget, and the election of board members, including both independent and non-independent directors [6] - Proposals 11 and 12 were subject to cumulative voting, and all candidates were successfully elected [6] - The special resolution regarding the cancellation of the supervisory board and amendments to the articles of association was passed with more than two-thirds of the voting shares in favor [6]
爱博医疗: 上海市方达(北京)律师事务所关于爱博诺德(北京)医疗科技股份有限公司2024年年度股东大会的法律意见书